Annalisa Jenkins, the former head of R&D at Merck Serono, is one of the people behind the investment fund.

with the German firm’s Merck Serono division licensing various technologies used to engineer T-cells to target cancers, including its RheoSwitch platform for controlling gene expression and ...

In this article, we are going to take a look at where Merck & Co Inc. (NYSE:MRK) stands against other undervalued quality stocks to buy now. On February 24, Kayne Anderson Rudnick chief market ...

Merck MRK is a healthcare company that manufactures pharmaceutical products to treat various conditions in many therapeutic areas, including cardiometabolic disease, cancer and infections ...

Ralston brings 25 years of experience in market access and health equity outcomes research, having worked at Genesis Research Group, Takeda, and Merck Serono. Gary Lyons has been appointed EVP ...

More recently, she debuted as the lead in EMD Serono’s I Was Ready for Change campaign. In that capacity, she has been raising awareness for the condition and Mavenclad (cladribine) tablets, which are ...

2007;8(1):39-49. Disclosure: Dr. Balcer has served as a consultant for development of visual outcomes for trials for Biogen Idec, Merck Serono, Sirtris Pharmaceuticals, Centocor, and Eisai.

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other value stocks in Ken Fisher’s portfolio. Trump’s “stupid” tariffs will fail ...

Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non–Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834 In the article that ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...